Charting the landscape for EGFR-positive NSCLC


Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate novel data in molecular testing for EGFR+ NSCLC
  • Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice



  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
  • Reinhard Büttner (Germany)
  • Sanjay Popat (UK)


This educational activity has been awarded 2 CPD points by CPDUK, a globally recognised provider of CPD.

More Info
60 Minutes
EM-69921 - Date of preparation: July 2021